Investing.com - Biohaven Pharma reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations. Biohaven Pharma announced ...

Biohaven Ltd. (NYSE:BHVN) Director Bailey Gregory has increased his stake in the company with a recent purchase of shares valued at approximately $999,000. The transaction, which... In a recent ...

Pre-Open Stock Movers: Biohaven Pharmaceutical (BHVN) 71% HIGHER; Pfizer Inc. (NYSE:PFE) and Biohaven Pharmaceutical Holding Company Ltd. (BHVN) today announced that the ...

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Biohaven wasn’t one of them. The 10 stocks that made the cut ...

News of a big and important regulator's move was the electricity that powered Biohaven (NYSE: BHVN) stock to an 11%-plus gain on the second trading day of the week. Its leading investigational drug is ...

Deutsche Bank analyst David Hoang initiated coverage on Biohaven with a Buy rating and a price target of $65.00 ... The company's stock movement reflects investor confidence in its strategic ...

Biohaven (BHVN) is jumping 10% after the FDA agreed to review the company’s potential treatment for a rare disease.

Before market open, Biohaven announced that the U.S. Food and ... That alone is worth considering its stock for a buy. Eric Volkman has no position in any of the stocks mentioned.

Deutsche Bank analyst David Hoang initiated coverage on Biohaven with a Buy rating and a price target of $65.00 ... a troriluzole Marketing Authorization Application. The company's stock movement ...

Biohaven (BHVN) is jumping 10% after the FDA ... If you are looking for an AI stock that is more promising than BHVN but that trades at less than 5 times its earnings, check out our report about ...